Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details) - Schedule of changes in options outstanding

v3.21.2
Stockholders' Equity (Details) - Schedule of changes in options outstanding - Options [Member]
9 Months Ended
Sep. 30, 2021
USD ($)
$ / shares
shares
Stockholders' Equity (Details) - Schedule of changes in options outstanding [Line Items]  
Number of Options, Outstanding and expected to vest, Beginning balance | shares 3,905,737
Weighted Average Exercise Price Per Share, Outstanding and expected to vest - Beginning balance | $ / shares $ 24.32
Weighted Average Remaining Contractual Term (Years), Beginning balance 8 years 4 months 24 days
Aggregate Intrinsic Value, Outstanding and expected to vest - Beginning balance | $ $ 48,952,339
Number of Options, Granted | shares 1,515,000
Weighted Average Exercise Price Per Share, Granted | $ / shares $ 33.46
Weighted Average Remaining Contractual Term (Years), Granted 9 years 3 months 10 days
Number of Options, Exercised | shares (160,556)
Weighted Average Exercise Price Per Share, Exercised | $ / shares $ 3.56
Weighted Average Remaining Contractual Term (Years), Exercised
Aggregate Intrinsic Value, Outstanding and expected to vest, Exercised | $
Number of Options, Forfeited | shares (216,250)
Weighted Average Exercise Price Per Share, Forfeited | $ / shares $ 39.61
Weighted Average Remaining Contractual Term (Years), Forfeited
Aggregate Intrinsic Value, Outstanding and expected to vest, Forfeited | $
Number of Options, Outstanding and expected to vest, Ending balance | shares 5,043,931
Weighted Average Exercise Price Per Share, Outstanding and expected to vest, Ending balance | $ / shares $ 27.07
Weighted Average Remaining Contractual Term (Years), Ending balance 8 years 2 months 4 days
Aggregate Intrinsic Value, Outstanding and expected to vest, Ending balance | $ $ 33,664,009
Number of Options, Options exercisable | shares 2,079,396
Weighted Average Exercise Price Per Share, Options exercisable | $ / shares $ 22.59
Weighted Average Remaining Contractual Term (Years), Options exercisable 7 years 6 months 14 days
Aggregate Intrinsic Value, Options exercisable | $ $ 21,827,709